financetom
Business
financetom
/
Business
/
Update: US Justice Department Sues to Break Up Ticketmaster-Parent Live Nation
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Update: US Justice Department Sues to Break Up Ticketmaster-Parent Live Nation
May 23, 2024 10:24 AM

12:28 PM EDT, 05/23/2024 (MT Newswires) -- (Updates with Live Nation's comments in fourth and fifth paragraphs, stock move in sixth paragraph.)

The US Justice Department and 30 state and district attorneys general sued Ticketmaster-parent Live Nation (LYV) Thursday, saying the company should be broken up because it has a monopoly in ticketing and concert promotion.

"We allege that Live Nation relies on unlawful, anticompetitive conduct to exercise its monopolistic control over the live events industry in the [US] at the cost of fans, artists, smaller promoters, and venue operators," said Attorney General Merrick Garland.

"The result is that fans pay more in fees, artists have fewer opportunities to play concerts, smaller promoters get squeezed out, and venues have fewer real choices for ticketing services. It is time to break up Live Nation-Ticketmaster."

The civil antitrust lawsuit was filed in the US District Court for the Southern District of New York.

"The DOJ's lawsuit won't solve the issues fans care about relating to ticket prices, service fees, and access to in-demand shows," Live Nation said in a statement to MT Newswires.

"Calling Ticketmaster a monopoly may be a PR win for the DOJ in the short term, but it will lose in court because it ignores the basic economics of live entertainment, such as the fact that the bulk of service fees go to venues, and that competition has steadily eroded Ticketmaster's market share and profit margin," Live Nation said.

Live Nation shares were falling 6.7% in recent trading.

Price: 94.66, Change: -6.74, Percent Change: -6.65

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Why VivoPower International Stock (VVPR) Is Up Over 300%
Why VivoPower International Stock (VVPR) Is Up Over 300%
Apr 2, 2024
VivoPower International PLC ( VVPR ) shares are trading higher by 323% to $6.18 during Tuesday’s session after the company’s Tembo subsidiary announced it will merge with the Nasdaq-listed Cactus Acquisition Corp. 1 Limited. VivoPower ( VVPR ) says the agreement entails exclusive negotiations for a business combination to merge with CCTS, with Tembo surviving the merger and changing its...
What's Going On With Sutro Biopharma (STRO) Stock?
What's Going On With Sutro Biopharma (STRO) Stock?
Apr 2, 2024
Sutro Biopharma Inc ( STRO ) shares are trading lower by 2.8% to $5.18 during Tuesday’s session after the company announced the pricing of an underwritten offering of 14,478,764 shares of its common stock at $5.18 per share, aiming to raise approximately $75 million. The offering, expected to close around April 4, involves all shares being offered by Sutro and...
Tesla quarterly deliveries decline for the first time in nearly four years
Tesla quarterly deliveries decline for the first time in nearly four years
Apr 2, 2024
(Reuters) - Tesla on Tuesday posted a decline in quarterly deliveries for the first time in nearly four years and missed Wall Street estimates, a performance some described as ugly as price cuts failed to stir demand in a highly competitive market. Shares of the Elon Musk-led company were down 5.3% at $165.98 at midday on Tuesday, losing about $30...
Some doses of Lilly's Mounjaro in tight supply through April, US FDA says
Some doses of Lilly's Mounjaro in tight supply through April, US FDA says
Apr 2, 2024
(Reuters) - Four doses of Eli Lilly's ( LLY ) diabetes drug Mounjaro would remain in tight supply through 2024 due to soaring demand, the U.S. Food and Drug Administration's website showed. The regulator noted limited availability of 7.5, 10, 12.5, and 15 milligram doses through April, while lower doses were listed as available. The FDA had previously said that...
Copyright 2023-2026 - www.financetom.com All Rights Reserved